Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

The Psoriasis Symptom Inventory (PSI), a self-administered, patient-reported outcome measure (PRO) to assess symptom severity in plaque psoriasis is available online at no cost for use in the clinic or for academic research and is available in 20 different languages.  

The IPC worked in collaboration with one of its industry partners to validate the tool for clinic use.   The project was led by IPC Board Member, Bruce Strober, USA and the following councilors and board members participated as study sites.  Kristina Callis-Duffin, USA; Yves Poulin, Canada; Richard Warren, UK; and Claudia de la Cruz, Chile.

The following paper was published on this study.  

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council. Strober B, van de Kerkhof PCM, Callis Duffin K, Poulin Y, Warren RB, de la Cruz C, van der Walt JM, Stolshek BS, Martin ML, de Carvalho AVE. Am J Clin Dermatol. 2019 Oct;20(5):699-709. doi: 10.1007/s40257-019-00458-2.

The PSI is available through Evidera at no cost for use in the clinic and academic research at this website.  

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


on SARS-CoV-2 Vaccines and Psoriasis

Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.